| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |